Fuller Andrea J, Bucklin Brenda
Department of Anesthesiology, University of Colorado Denver Health Sciences Center, 4200 E. 9th Avenue, B-113, Denver, CO 80262, USA.
Obstet Gynecol Clin North Am. 2007 Sep;34(3):443-58, xi. doi: 10.1016/j.ogc.2007.06.003.
Hemorrhage is the leading cause of intensive care unit admission and one of the leading causes of death in the obstetric population. This emphasizes the importance of a working knowledge of the indications for and complications associated with blood product replacement in obstetric practice. This article provides current information regarding preparation for and administration of blood products, discusses alternatives to banked blood in the obstetric population, and introduces pharmacological strategies for treatment of hemorrhage.
出血是重症监护病房收治的主要原因,也是产科人群主要死因之一。这凸显了在产科实践中掌握血液制品替代治疗的适应证及相关并发症实用知识的重要性。本文提供了有关血液制品准备和输注的当前信息,讨论了产科人群中库存血的替代方法,并介绍了治疗出血的药理学策略。